Y-mAbs Therapeutics Inc Sustainability Reports
Y-Mabs Therapeutics Inc. is a biopharmaceutical company focused on developing novel antibody-based therapies for the treatment of cancer and other serious diseases.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US9842411095
1 reports from 2024 to 2024
Company Profile
Y-mAbs Therapeutics Inc
Y-Mabs Therapeutics Inc. is a biopharmaceutical company focused on developing novel antibody-based therapies for the treatment of cancer and other serious diseases.
Reports